Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
The New England Journal of Medicine|August 28, 2018
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus, Louise Bowman, Marion Mafham, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 2, 2025
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEYGreco B Malijan, Rebecca J Sardell, Natalie Staplin, et al.
Transplantation Research|May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolRichard Haynes, Colin Baigent, Paul Harden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Lancet (London, England)|September 1, 2022
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trialsAlex Pitcher, Enti Spata, Jonathan Emberson, et al.
American Journal of Hematology|June 15, 2024
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trialBianca Rocca, Alberto Tosetto, Giovanna Petrucci, et al.
Pageof 20